Urology · KIMS Secunderabad
Overactive Bladder (OAB) — Sudden Urge to Urinate, Frequency, and What to Do About It
Overactive bladder (OAB) is one of the most common and most under-treated urological conditions in India. It affects an estimated 1 in 6 adults — men and women — and yet the majority of people with OAB never seek medical help. The reasons are familiar: embarrassment about discussing bladder symptoms, the mistaken belief that urgency and frequency are normal parts of ageing, and the resignation that nothing can be done. All three assumptions are wrong.
OAB is a clinical syndrome defined by urinary urgency — a sudden, compelling desire to urinate that is difficult to defer — usually accompanied by urinary frequency (urinating 8 or more times in 24 hours), and often by nocturia (waking at night to urinate) and urge urinary incontinence (leaking urine before reaching the toilet). It is not a minor inconvenience — it restricts daily activities, disrupts sleep, causes social withdrawal, and carries a significant psychological burden. And it is highly treatable, with first-line interventions achieving meaningful improvement in most patients.
What causes overactive bladder
OAB results from abnormal detrusor muscle contractions — the smooth muscle of the bladder wall contracts involuntarily and prematurely, generating urgent pressure before the bladder is full. This may or may not be associated with neurological disease.
Idiopathic OAB (most common)
No identifiable neurological cause. The detrusor overactivity is not explained by neurological disease, obstruction, or local bladder pathology. This accounts for the majority of OAB in the general population. Underlying contributors include: ageing (reduced cortical inhibition of bladder contractions), bladder outlet obstruction from BPH in men (the obstructed, high-pressure bladder develops secondary detrusor overactivity), oestrogen deficiency in postmenopausal women (reduced urethral and bladder neck mucosal integrity), caffeine and alcohol intake (both are diuretics and bladder irritants), obesity, constipation (a full rectum reduces bladder capacity), and anxiety (heightened sensory awareness of bladder filling).
Neurogenic OAB
Detrusor overactivity secondary to neurological disease — stroke (loss of cortical inhibition), Parkinson's disease, multiple sclerosis, spinal cord injury, or diabetic autonomic neuropathy. These patients require careful urodynamic evaluation because the treatment approach and the risk of upper tract damage are different from idiopathic OAB. See /conditions/neurogenic-bladder/ for full detail.
Secondary OAB
OAB symptoms caused by bladder pathology — urinary tract infection (the most common reversible cause of urgency and frequency — always exclude infection first), bladder stone, bladder tumour, radiation cystitis, or interstitial cystitis. These causes must be excluded before diagnosing primary OAB.
Before starting any treatment for OAB, urinary tract infection must be excluded with a midstream urine culture. Infection causes urgency and frequency identical to OAB and must be treated with antibiotics — not with OAB medications.
Symptoms — the OAB spectrum
OAB is a symptom syndrome, not a single complaint. The five features below — alone or in combination — define the clinical picture and are the basis for the OABSS and ICIQ symptom scores used at KIMS.
Urgency
The cardinal symptom. A sudden, strong desire to urinate that is difficult to delay and does not build gradually — it arrives abruptly and may be triggered by sound of running water, arriving home (the 'latchkey' urgency), cold weather, or emotional stress.
Frequency
Urinating 8 or more times in 24 hours (or more frequently than every 2 hours during the day). Many OAB patients urinate every 30 to 60 minutes out of fear of leakage rather than true bladder fullness.
Urge urinary incontinence (UUI)
Urine leakage that occurs simultaneously with or immediately after the urgency episode — before reaching the toilet. Affects approximately 33% of OAB patients. 'OAB dry' = urgency and frequency without leakage. 'OAB wet' = urgency with incontinence.
Nocturia
Waking from sleep one or more times to urinate. Significantly disrupts sleep quality. See the KIMS nocturia page for a detailed discussion.
Anxiety and social restriction
OAB profoundly affects quality of life — mapping exit routes before entering any building, avoiding travel, restricting fluid intake to dangerous levels, withdrawing from social activities. The psychological impact is often underappreciated by clinicians.
Diagnosis at KIMS
OAB is a clinical diagnosis supported by a structured workup that confirms the pattern, excludes infection and other secondary causes, and quantifies severity so that treatment response can be objectively assessed.
Symptom assessment — OABSS or ICIQ questionnaire
Objective scoring of urgency, frequency, nocturia, and incontinence severity. Also used to measure treatment response.
Bladder diary
3-day frequency-volume chart recording every void, volume, urgency episode, and incontinence episode. Identifies 24-hour voiding pattern, maximum and average bladder capacity, fluid intake, and nocturnal urine production. Essential for diagnosis and treatment planning.
Urine dipstick and culture
To exclude infection, haematuria, and glucose.
Uroflowmetry and post-void residual (PVR)
Urine flow rate and residual urine volume after voiding. Poor flow and high PVR in a man suggests bladder outlet obstruction from BPH as the underlying cause of OAB symptoms.
Urodynamic study (cystometry)
Performed where the diagnosis is uncertain, symptoms are severe, or treatment has failed. Measures bladder filling pressure, detrusor contractions, and bladder capacity during controlled filling. At KIMS, urodynamics is performed in the urology department. The key finding in OAB is detrusor overactivity — involuntary detrusor contractions during filling that may or may not cause urgency.
Cystoscopy
Performed where haematuria is present alongside OAB symptoms, to exclude bladder tumour or stone as a secondary cause.
Treatment — the stepped approach
Overactive bladder (OAB) treatment follows a structured escalation pathway. Lifestyle and behavioural measures form the foundation of treatment and remain important even when medications or specialist interventions are added later.
Step 1: Lifestyle and behavioural measures — always first
Fluid management
Aim for 1.5 to 2 litres of fluid per day. More causes frequency; less causes concentrated urine that irritates the bladder. Reduce or eliminate caffeine (coffee, tea, cola drinks) and alcohol — both are diuretics and bladder irritants. Avoid large fluid intake after 6pm to reduce nocturia.
Bladder training
A structured programme of progressively increasing the interval between voids, starting from the current voiding interval and increasing by 15 minutes every 1 to 2 weeks, working toward a 3 to 4 hour voiding interval. Requires discipline — urgency suppression techniques (pelvic floor contraction, distraction) are taught alongside the timing programme.
Pelvic floor muscle training (PFMT)
Voluntary contraction of the pelvic floor muscles at the onset of urgency inhibits the detrusor contraction (the guarding reflex). PFMT also improves urge incontinence by increasing urethral sphincter tone. Supervised PFMT by a trained physiotherapist achieves significantly better outcomes than unsupervised exercises.
Weight loss
Obesity increases intra-abdominal pressure and OAB severity. Weight loss of 5 to 10% of body weight reduces urgency incontinence episodes significantly.
Step 2: Pharmacological treatment
Antimuscarinics (oxybutynin, solifenacin, tolterodine, fesoterodine)
The established class of OAB medications — block muscarinic receptors on the detrusor muscle, reducing involuntary contractions. Solifenacin and fesoterodine have more selective bladder action than oxybutynin (fewer central nervous system and dry mouth side effects). Effective in 60 to 70% of patients. Must be used for 4 to 8 weeks before assessing response. Should not be used in patients with significant post-void residual (urinary retention risk) or cognitive impairment (CNS effects of older agents).
Beta-3 agonists (mirabegron)
A newer class — activates beta-3 receptors in the detrusor, causing muscle relaxation during filling without reducing contractility during voiding. No anticholinergic side effects (no dry mouth, no cognitive effects). Effective in patients who cannot tolerate antimuscarinics. Safe in elderly patients. Can be combined with antimuscarinics for refractory cases.
Step 3: Specialist interventions (when step 1 and 2 fail)
Intradetrusor botulinum toxin (Botox)
100 units of onabotulinumtoxinA injected into the detrusor muscle wall at cystoscopy. Inhibits the release of acetylcholine at the neuromuscular junction, reducing involuntary contractions. Effective in 70 to 80% of refractory OAB patients. Duration 6 to 12 months — re-injection as needed. Small risk of urinary retention (requiring temporary self-catheterisation).
Percutaneous tibial nerve stimulation (PTNS)
Neuromodulation via the posterior tibial nerve (ankle), which shares sacral nerve roots with the bladder. 12 weekly 30-minute sessions. Effective in approximately 60% of refractory OAB patients. No surgical risk. Available at KIMS.
Sacral neuromodulation (Interstim)
Implantable device that delivers continuous electrical stimulation to the S3 sacral nerve root, modulating the micturition reflex. Requires surgical implantation under general anaesthesia. Highly effective for refractory OAB.
Book an OAB Assessment at KIMS — Urodynamics Available
Frequently Asked Questions — Overactive Bladder
Urinating 4 to 7 times during the day and once at night is generally considered normal for an adult drinking 1.5 to 2 litres of fluid daily. Urinating 8 or more times in 24 hours — or more frequently than every 2 hours — is clinically significant frequency that warrants investigation. 'Normal' must also be distinguished from 'common' — frequency and urgency become more common with age, but they are symptoms of a condition, not an inevitable consequence of ageing. They are treatable regardless of age.
These are two distinct conditions with different causes, different treatments, and different symptom patterns. Overactive bladder (urgency urinary incontinence) involves leakage associated with a sudden, uncontrollable urge to void — triggered by the detrusor contracting involuntarily. Stress urinary incontinence involves leakage triggered by physical exertion — coughing, sneezing, laughing, jumping — caused by inadequate urethral sphincter support, not an abnormal bladder contraction. The distinction is important because OAB is treated with bladder training and antimuscarinic medications, while stress incontinence is treated with pelvic floor rehabilitation and surgery (urethral sling). Many women have mixed incontinence — both components — requiring a combined assessment.
Yes — caffeine is both a diuretic and a direct bladder irritant. It increases urinary frequency by increasing urine production and by directly stimulating bladder wall contractions. Studies consistently show that reducing caffeine intake (coffee, strong tea, energy drinks, cola drinks containing caffeine) reduces urgency and frequency in OAB patients. The effect is dose-dependent — a complete switch from caffeinated to decaffeinated beverages produces a more significant improvement than reducing coffee by one cup per day. Reducing caffeine is the single most evidence-based dietary change for OAB and is the first lifestyle intervention recommended at KIMS.
OAB itself is not a dangerous condition — but it must be investigated to exclude serious causes of similar symptoms. Haematuria (blood in the urine) alongside urgency and frequency warrants urgent cystoscopy to exclude bladder cancer. Rapidly developing OAB symptoms with neurological features (leg weakness, numbness, difficulty walking) suggest a spinal cord or neurological cause requiring urgent imaging. New-onset OAB symptoms with significant post-void residual in a man suggest bladder outlet obstruction from BPH requiring specific treatment. In the absence of these red flags, OAB is a benign but bothersome functional disorder.
Not in the way most patients assume — and potentially harmfully. Restricting fluid intake to below 1 litre per day concentrates the urine, which makes it more irritating to the bladder lining and worsens urgency and frequency. It also increases the risk of urinary tract infection and kidney stone formation. The correct approach is 1.5 to 2 litres of fluid per day — evenly distributed, avoiding large volumes at any one time, and reducing intake after 6pm to decrease nocturia. The type of fluid also matters: water and dilute squash are least irritating; caffeine, alcohol, and fizzy drinks are the most irritating.
Bladder training — progressively increasing the interval between voids — requires 6 to 12 weeks of consistent practice before meaningful improvement is achieved. The initial voiding interval (the current average time between voids) is increased by 15 minutes every 1 to 2 weeks, using urgency suppression techniques (pelvic floor contraction, distraction) to bridge the gap between the urgent desire and the scheduled void time. At 12 weeks, most patients have extended their voiding interval from 30 to 45 minutes to 2 to 3 hours with significantly reduced urgency. Bladder training combined with pelvic floor exercises produces better outcomes than either alone.
Urodynamics is a specialised investigation that measures bladder pressure, flow rate, and bladder behaviour during controlled filling and voiding. For straightforward OAB diagnosed on symptoms and bladder diary, urodynamic testing is not required before starting treatment. It is recommended when: the diagnosis is uncertain (mixed or atypical symptoms), OAB treatment has failed, neurological disease is present, there is significant post-void residual, or surgery is being considered. At KIMS, urodynamics is performed by the urology team as an outpatient test with results available on the same day.
KIMS Secunderabad — Dr. Neil Narendra Trivedi (MCh Urology KEM Hospital Mumbai, Member SIU), full OAB assessment including bladder diary, uroflowmetry, post-void residual, and urodynamics, full treatment pathway from behavioural measures through antimuscarinics and beta-3 agonists to intradetrusor Botox and PTNS neuromodulation. NABH and NABL accredited. Call 040-4488-5000.